From Wikipedia, the free encyclopedia
Jump to: navigation, search
Monoclonal antibody
Type Whole antibody
Source Human
Target CD30
CAS Number 640735-09-7 N
ATC code none
ChemSpider none
KEGG D04612 YesY
Chemical data
Formula C6358H9830N1682O1992S38
Molar mass 170 kg/mol
 NYesY (what is this?)  (verify)

Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease.[1]

This drug was developed by Medarex, Inc.


  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council – Iratumumab, American Medical Association.